DEXTROSE+SODIUM CHLORIDE

This brand name is authorized in Nigeria.

Active ingredients

The drug DEXTROSE+SODIUM CHLORIDE contains a combination of these active pharmaceutical ingredients (APIs):

1	Glucose UNII LX22YL083G - DEXTROSE MONOHYDRATE
	Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body.
	Read more about Glucose
2	Sodium chloride UNII 451W47IQ8X - SODIUM CHLORIDE
	Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.
	Read more about Sodium chloride

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0236	Solution for infusion	5% Dextrose and Normal Saline Infusion INJ_SOL 5%; 0.9% 250 mL; 500 mL; 1000 mL (in transparent LDPE bottles)	Solution for infusion. Clear solution, free from visible particles	31/01/2024
A11-100457	Solution for infusion	Dele Fluids Dextrose 5%w/v + 0.9%w/v Sodium Chloride INJ_SOL 5%; 0.9% 500 mL (in PVC pouch)	Solution for infusion. Clear solution, free from visible particles	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05BB02	Electrolytes with carbohydrates	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BB Solutions affecting the electrolyte balance
Discover more medicines within B05BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0236, A11-100457